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Abstract
Background  and  objectives:  We  aimed  to  evaluate  the  effect  of  bupivacaine  and  dexmedeto-
midine added  to  bupivacaine  used  in  tranversus  abdominis  plane  (TAP)  block  on  postoperative
pain and  patient  satisfaction  in  patients  undergoing  lower  abdominal  surgery.
Methods:  Lower  abdominal  surgery  was  enrolled  in  the  study.  After  anesthesia  induction,  ultra-
sound guided  TAP  block  was  performed.  TAP  block  was  obtained  with  21  mL  0.9%  saline  in
Group C  (n  =  31),  20  mL  0.5%  bupivacaine  +  1  mL  saline  in  Group  B  (n  =  31),  and  20  mL  0.5%
bupivacaine  +  1  mL  dexmedetomidine  (100  g)  in  Group  BD  (n  =  31).
Results: Visual  analog  scale  scores  were  lower  in  Group  BD  compared  to  Group  C,  at  all  time
points (p  <  0.05);  it  was  lower  in  group  BD  than  in  group  B  at  10--24  h.  In  Group  B,  it  was  lower
than Group  C  at  2--8  h  (p  <  0.05).  Total  morphine  consumption  was  lower  in  Group  BD  com-
pared to  other  groups  and  lower  in  group  B  than  in  the  controls  (p  <  0.001).  Patient  satisfaction
was higher  in  Group  BD  than  in  other  groups  and  was  higher  in  both  study  groups  than  in  the
controls  (p  <  0.001).  Nausea-vomiting  scores,  antiemetic  requirement,  or  additional  analgesic
administration  were  not  signiﬁcant  among  groups  (p  >  0.05).
Conclusions:  The  addition  of  dexmedetomidine  to  bupivacaine  on  TAP  block  decreased  postop-
erative pain  scores  and  morphine  consumption;  it  also  increased  patient  satisfaction  in  patients
undergoing lower  abdominal  surgery.  Dexmedetomidine  did  not  have  any  effect  on  nausea  and
vomiting score  and  antiemetic  requirement.r  Editora  Ltda.  on  behalf  of  Sociedade  Brasileira  de  Anestesiologia.
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Eﬁcácia  de  bupivacaína  e  associac¸ão  com  dexmedetomidina  em  bloqueio  do  plano
transverso  abdominal  guiado  por  ultrassom  na  dor  após  cirurgia  abdominal
Resumo
Justiﬁcativa  e  objetivos:  O  objetivo  do  estudo  foi  avaliar  o  efeito  de  bupivacaína  e  dexmedeto-
midina adicionadas  à  bupivacaína  para  bloqueio  do  plano  transverso  abdominal  (TAP)  no  controle
da dor  e  satisfac¸ão  do  paciente  após  cirurgia  abdominal  inferior.
Métodos:  Pacientes  submetidos  à  cirurgia  abdominal  inferior  foram  incluídos  no  estudo.  Após  a
induc¸ão da  anestesia,  o  bloqueio  TAP  guiado  por  ultrassom  foi  realizado  com  21  mL  de  soluc¸ão
salina a  0.9%  no  Grupo  C  (n  =  31),  20  mL  de  bupivacaína  a  0,5%  +  1  mL  de  soluc¸ão  salina  no  Grupo  B
(n =  31)  e  20  mL  de  bupivacaína  a  0,5%  +  1  mL  de  dexmedetomidina  (100  g)  no  grupo  BD  (n  =  31).
Resultados:  Os  escores  da  escala  visual  analógica  foram  menores  no  Grupo  BD  comparado  ao
Grupo C  em  todos  os  tempos  mensurados  (p  <  0,05);  foi  menor  no  Grupo  BD  que  no  Grupo  B  em
10-24 horas.  No  Grupo  B,  os  escores  VAS  foram  menores  que  no  Grupo  C  em  2-8  horas  (p  <  0,05).
O consumo  total  de  morﬁna  foi  menor  no  Grupo  BD  em  comparac¸ão  com  outros  grupos  e  menor
no Grupo  B  que  nos  controles  (p  <  0,001).  A  satisfac¸ão  do  paciente  foi  maior  no  Grupo  BD  que
nos outros  grupos  e  maior  em  ambos  os  grupos  de  estudo  que  nos  controles  (p  <  0,001).  Os
escores de  náusea  e  vômito,  necessidade  de  antiemético  ou  de  analgésicos  adicionais  não  foram
signiﬁcativos  entre  os  grupos  (p  >  0,05).
Conclusões:  A  adic¸ão  de  dexmedetomidina  à  bupivacaína  em  bloqueio  TAP  reduziu  os  escores  de
dor e  o  consumo  de  morﬁna  no  pós-operatório,  além  de  aumentar  a  satisfac¸ão  do  paciente  em
pacientes submetidos  à  cirurgia  abdominal  inferior.  Dexmedetomidina  não  apresentou  efeito
sobre os  escores  de  náusea  e  vômito  e  a  necessidade  de  antiemético.
© 2016  Publicado  por  Elsevier  Editora  Ltda.  em  nome  de  Sociedade  Brasileira  de  Anestesiologia.
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evaluation,  or  the  surgeons  performing  the  operation,  were
given  information  on  the  groups.  All  patients  receivedlicenses/by-nc-nd/4.0/).
ntroduction
pen  inguinal  hernioplasty  and  open  appendectomy  surgery
ostly  cause  mild  to  severe  postoperative  pain.1--3 If  not
reated,  postoperative  pain  leads  to  chronic  pain  and
ndesirable  events  ranging  from  patient  discomfort  and
rolonged  immobility  to  thrombolytic  phenomenon  and  pul-
onary  complications.4,5 Regarding  chronic  pain  formation,
ostoperative  pain  state,  and  nerve  injury  during  surgery,
s  well  as  insufﬁcient  early  postoperative  pain  control,  are
mong  the  risk  factors.4,6 Expected  pain  prevalence  follow-
ng  hernia  repair  was  determined  as  54%  and  postoperative  2
ear  cumulative  prevalence  was  found  to  be  30%.7 Transver-
us  abdominal  plane  (TAP),  one  of  the  peripheral  nerve
locks,  was  reported  to  reduce  postoperative  pain  follow-
ng  hysterectomy,  colorectal  surgery,  appendectomy,  and
nguinal  hernioplasty.2,3,8--10
TAP  is  located  between  the  oblique  muscles  and  the
ransverse  abdominis  muscles.  On  TAP  iliohypogastric  nerve
ies  and  anterolateral  abdominal  wall  afferent  T6-L1  nerves
s  got  blocked  with  blockage  of  this  area.1,5
Single  and  continuous  TAP  block  techs  have  been  suc-
essfully  administered  for  pain  control  in  the  repair  of
nguinal  hernia.11,12 However,  the  duration  of  single-dose
dministered  TAP  block  is  limited  to  the  effect  of  admin-
stered  local  anesthetics.  Addition  of  adjuvant  to  local
nesthesia  may  prolong  the  block’s  duration.13 Dexmedeto-
idine  is  a  selective  alpha-2  adrenergic  agonist  with  both
nalgesic  and  sedative  properties.14 When  administered  as
 perineural  adjuvant,  dexmedetomidine  reduces  initialPlease  cite  this  article  in  press  as:  Aksu  R,  et  al.  Efﬁciency  o
transversus  abdominis  plane  block  ultrasound  guided  in  posto
2016.  http://dx.doi.org/10.1016/j.bjane.2016.08.003
locking  time  whilst  prolonging  sensory  and  motor  blockade
uration.15
s
aaterials and methods
ocal  ethics  approval  for  the  study  was  received
2014/37).  Then  the  study  was  recorded  on
ttp://www.clinicaltrials.gov  (NCT02064530).  After
eceiving  written  consent  from  the  patients,  93  ASA
--II  patients  aged  18--65  years  were  included  in  the  study
nd  scheduled  for  open  appendectomy  repair  or  inguinal
ernia  administrations.  A  placebo-controlled,  randomized,
rospective  and  triple-blinded  study  was  carried  out,
nd  blinding  was  applied  both  to  the  patients  and  to  the
nvestigators  and  data  collection  team.  Patients  were
xcluded  if  they:  had  a  history  of  allergy  to  bupivacaine
nd  dexmedetomidine;  were  or  may  have  been  pregnant;
ad  a  coagulation  disorder,  serious  cardiac  and  pulmonary
isease;  had  an  administration  site  infection;  or  were
nable  to  understand  the  scoring  system.  Patients  were
andomized  with  sealed  envelopes.  The  control  group
Group  C)  (n  =  31),  bupivacaine  group  (Group  B)  (n  =  31)  and
upivacaine  + dexmedetomidine  group  (Group  BD)  (n  =  31)
ere  determined.  The  Groups  C,  B,  and  BD  were  given,
espectively,  21  mL  0.9%  NaCl,  20  mL  0.5%  bupivacaine
without  epinephrine)  (Bustesin® 5  mg/mL,  Vem  Pharma-
euticals,  Ankara,  Turkey)  + 1  mL  0.9%  NaCl  solution,  and
0  mL  0.5%  bupivacaine  (without  epinephrine)  and  100  g
1  mL)  dexmedetomidine  (Precedex® 100  g/mL,  Meditera,
BD).  None  of  the  patients,  or  the  investigators  adminis-
rating  the  TAP  block  and  carrying  out  the  postoperativef  bupivacaine  and  association  with  dexmedetomidine  in
perative  pain  of  abdominal  surgery.  Rev  Bras  Anestesiol.
tandard  general  anesthesia  under  standard  monitorization,
nd  perioperative  mean  arterial  pressure  (MAP)  and  heart
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Transversus  abdominis  plane  block  
rate  (HT)  values  were  recorded.  Anesthesia  was  induced
by  administration  of  5--7  mg/kg  thiopental  (Pental®,  Ula-
gay,  Turkey),  0.6  mg/kg  rocuronium  bromide  (Esmeron®,
Schering-Plough,  Holland)  and  1  g/kg  fentanyl  (Talinat®,
Vem  Pharmaceuticals,  Istanbul,  Turkey).  When  muscles
were  sufﬁciently  relaxed,  endotracheal  intubation  was
performed.  Patients  were  monitored  and  ventilated  with  an
electronic  anesthesia  device  (S/5  Avance,  Datex  Ohmeda,
Finland).
For  anesthesia  supply,  4--6%  desﬂurane  (Suprane® Liq-
uid  100%,  Abbott,  Norway)  was  added  to  50%  oxygen  +  50%
nitrogen  mixture.  It  was  projected  to  administer  1  g/kg
intravenous  fentanyl  in  any  case  where  MAP  and  HT  values  go
up  to  20%  over  basal  values  before  induction.  A  MAP  decrease
of  more  than  20%  was  considered  to  be  hypotension.  In
such  cases,  desﬂurane  concentration  would  be  reduced  and
5  mg  ephedrine  would  be  intravenously  administered,  if  nec-
essary.  Slowing  down  of  the  heart  rate  to  less  than  50
beats/min  was  considered  to  be  bradycardia,  and  0.5  mg
atropine  was  planned  to  be  administered  in  these  cases.
The  skin  antiseptic  was  provided  with  2%  chlorhexidine
solution  following  anesthesia  induction.  A  high-frequency
(5--10  MHz)  ultrasound  linear  probe  (Mindray  M7,  China)
was  transversely  located  on  the  anterolateral  abdominal
wall  between  the  iliac  crest  and  the  subcostal  area,  and
neurophasia  (TAP)  between  the  internal  oblique  and  tran-
verse  abdominis  was  identiﬁed.  A  50  mm  nerve  block  needle
(Braun  Melsungen  AG,  Melsungen,  Germany)  was  concur-
rently  located  on  the  area  and  pre-prepared  agent  was
injected  after  negative  aspiration.  The  injected  liquid  was
observed  on  ultrasound  to  be  distributed  in  a  dark  oval  form
in  TAP.  Surgical  procedure  started  after  performing  TAP  block
and  distance  between  start  and  stop  point  of  wound  incision
was  recorded  as  length  of  incision.
Anesthesia  was  discontinued  following  surgical  oper-
ation  and  residual  block  was  reversed  using  0.02  mg/kg
atropine  (Atropin  Sülfat® 0.25  mg/mL,  Biofarma,  Istan-
bul,  Turkey)  and  0.04  mg/kg  neostigmin  (Neostigmine®
0.5  mg/mL,  Adeka,  Turkey).  When  the  patient  came  out
of  anesthesia  and  had  spontaneously  gained  sufﬁcient  tidal
volume  and  motor  function,  they  were  transferred  to  the
Postoperative  Care  Unit  (PCU).  One  gram  of  paracetamol
(Perfalgan®,  Bristol-Myers  Squibb,  USA)  was  intravenously
administered  as  a  standard  postoperative  anesthesia  regime
and  attached  to  a  Patient-Controlled  Analgesia  (PCA),
device  solution  was  prepared  by  adding  100  mg  morphine
(Morphine® 10  mg/mL,  Galen,  Istanbul,  Turkey)  to  250  mL
0.9%  NaCl.  The  PCA  device  was  set  to  have  a  7  min  lockout
time  and  a  0.5  mg  bolus.  Cases  were  transferred  to  general
surgery  after  2  h  follow-up  in  PCU  during  the  postopera-
tive  period.  The  severity  of  pain  at  rest  was  assessed  using
a  10  cm  Visual  Analog  Scale  (VAS),  scaled  from  left;  0 =  no
pain,  to  right;  10  =  worst  imaginable  pain,  and  recorded
post-operative  0,  2,  6,  8,  10,  12,  18  and  24  h.
Patients  with  a  VAS  score  of  more  than  4  during  assess-
ment  were  given  50  mg  i.v.  diclofenac  sodium  (Dicloron®,
Abbott,  Norway).  The  doses  of  morphine  and  analgesic  con-
sumed  were  recorded.  The  satisfaction  of  patients  wasPlease  cite  this  article  in  press  as:  Aksu  R,  et  al.  Efﬁciency  o
transversus  abdominis  plane  block  ultrasound  guided  in  posto
2016.  http://dx.doi.org/10.1016/j.bjane.2016.08.003
recorded  in  the  24th  hour  following  operation.  Patient
satisfaction  assessment  scores  were:  1  --  poor,  2  --  moder-
ate,  3  --  good,  4  --  perfect.16 Patients  were  monitored  for
24  h  in  terms  of  nausea,  vomiting,  altered  mental  status,
i
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ypotension,  hypertension,  bradycardia,  and  tachycardia,
ll  of  which  might  occur  as  a  result  of  the  drugs  adminis-
ered.  Nausea  and  vomiting  assessment  scores  were:  1  --
one,  2  --  nausea,  3  --  retching,  4  --  vomiting.  All  patents
aving  nausea,  retching  or  vomiting  were  planned  to  be
iven  an  antiemetic.8 In  the  presence  of  nausea--vomiting,
t  was  planned  to  administer  10  mg  i.v.  metoclopramide
CL  (Primperan®, Biofarma,  Turkey)  ﬁrst,  and  then  4  mg  i.v.
ndansetron  (Zofran®, GlaxoSmithKline,  Italy)  following  1  h
ollow-up  if  necessary.  The  primary  outcome  of  this  study
as  to  assess  morphine  consumption  for  post-operative  pur-
ose.  The  secondary  aim  was  to  meet  patient’s  satisfaction
ith  respect  to  pain  scores  assessed  with  VAS  within  the
ostoperative  24  h  period,  period  of  hospitalization,  nau-
ea,  vomiting  and  antiemetic.  To  calculate  sample  size  for
he  study,  10  cases  were  pre-studied  and  the  averages  of
ostoperative  24  h  morphine  consumption  calculated.  When
lpha  is  0.05,  and  ˇ  (the  false  negative  rate)  is  0.20,  and  the
inimum  mean  difference  is  6.3  mg  and  expected  standard.
tatistical analysis
ata  was  statistically  assessed  using  the  Statistical  Package
or  the  Social  Sciences  (SPSS  for  Windows,  Version  21.0,
BM  Corp,  Armonk,  NY).  The  Shapiro--Wilk  normality  test
as  used  to  determine  whether  sample  distribution  was
ormal  or  not.  Descriptive  statistics  unit  number  (n)  was
iven  as  mean  ±  standard  deviation  and  median  (min--max)
alues.  One  way  analysis  of  variance  (ANOVA)  was  used  to
valuate  whether  there  was  a  difference  among  groups  of
aving  normal  distribution.  To  evaluate  parameters  having
bnormal  distribution,  the  Kruskal--Wallis  test,  one  of  the
on-parametric  tests,  was  used.
The  signiﬁcant  ones  were  compared  using  pairwise  com-
arisons  and  it  was  determined  that  which  group  has
tatistical  difference.  A  value  of  p  <  0.05  was  accepted  as
tatistically  signiﬁcant.
esults
o  signiﬁcant  difference  was  observed  in  age,  weight,
ength,  body  mass  index,  gender,  ASA  class,  surgery  type,
urgery  duration,  length  of  incision,  discharge  duration,  or
ntraoperative  to  fentanyl  consumption  (p  >  0.05)  (Table  1).
hen  compared  to  Group  C,  a  signiﬁcant  decrease  in  heart
ate  was  observed  in  Groups  B  and  BD  in  the  10th,  30th,
5th,  and  60th  minutes  of  the  operation  (p  <  0.05)  (Fig.  1).
uring  the  postoperative  period,  the  increase  continued  in
roup  BD  in  0  and  24th  h  in  comparison  with  Group  C,  and
n  the  120th  min,  6th,  and  12th  h  in  comparison  to  both
roup  C  and  Group  B  (p  <  0.05)  (Fig.  1).  In  the  assessment
f  heart  rate  within  groups,  a  fall  according  to  initial  heart
ates  was  observed  in  the  10th,  30th,  45th,  and  60th  min-
tes  of  operation  in  Group  B,  and  at  every  measurement
ime  excluding  the  postoperative  24  h  in  Group  BD  (p  <  0.05).
owever,  0.5  mg  atropine  was  needed  as  two  of  the  patients’
R  went  below  50  beats/min.  No  difference  compared  tof  bupivacaine  and  association  with  dexmedetomidine  in
perative  pain  of  abdominal  surgery.  Rev  Bras  Anestesiol.
nitial  values  was  noticed  in  Group  C  (p  >  0.05)  (Fig.  1).
In  comparison  to  Group  C,  a  decrease  in  the  normal  clin-
cal  level  of  blood  pressure  mean  was  observed  in  the  10th
inute  of  the  operation  in  Group  B;  in  the  30th,  45th  and
ARTICLE IN PRESS+ModelBJANE-818; No. of Pages 8
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Table  1  Demographic  characteristics,  hospital  stay  and  intraoperative  fentanyl  consumption.  Data  are  given  as  mean  (SD)  or
number (%).
Group  C
(n =  31)
Mean  ±  SD
Group  B
(n =  31)
Mean  ±  SD
Group  BD
(n =  31)
Mean  ±  SD
p
Age  (years)  44.2  ±  13.9  43.5  ±  15.0  43.2  ±  15.0  0.962
Weight (kg)  80.8  ±  14.6  76.3  ±  12.0  77.1  ±  6.9  0.279
Height (cm)  172.6  ±  7.2  171.2  ±  6.5  174.1  ±  7.4  0.290
BMI 27.4  ±  5.0  26.0  ±  3.7  2.0  ±  5.5  0.445
Gender (F/M)
n (%)
7  (22.6)
24  (77.4)
7  (22.6)
24  (77.4)
6  (19.4)
25  (80.6)
0.439
ASA (I/II)
n  (%)
24  (77.4)
7 (22.6)
24  (77.4)
7 (22.6)
28  (90.3)
3 (9.7)
0.127
Duration  of  surgery  (min)  90.3  ±  36.3  77.1  ±  34.6  71.2  ±  21.5  0.054
Length of  incision  (cm)  6.9  ±  1.5  6.8  ±  1.6  7.4  ±  1.6  0.295
Hospital stay  (day/med/min--max) 1  (1--2)  1  (1--2)  1  (1--2)  0.424
I.O. fentanyl  (mcg) 101.6  ±  8.9  98.3  ±  8.9  98.4  ±  5.4  0.451
Surgery type  (n) 0.468
Inguinal  hernia 21  21  21
Perf. appendectomy 5  4  4
Non-perf. appendectomy 5  6  6
C, control; B, bupivacaine; BD, bupivacaine + dexmedetomidine; ASA, American Society of Anesthesiologists; BMI, body mass index; I.O.,
intra operative; Perf, perfore.
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Figure  1  Heart  rate  (HR)  (beats/min).  Data  are  given  as
median  (min--max)  or  mean  (SD).  ATB,  after  TAP  block;
PO, postoperative;  C,  control;  B,  bupivacaine;  BD,  bupiva-
caine  +  dexmedetomidine.  (a)  Signiﬁcant  difference  from  Group
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Figure  2  Mean  blood  pressure  (MBP)  (mmHg).  Data  are  given
as median  (min--max)  or  mean  (SD).  ATB,  after  TAP  block;
PO, postoperative;  C,  control;  B,  bupivacaine;  BD,  bupiva-
c
C
B
(
g
v
a; (b)  signiﬁcant  difference  from  Group  B;  (A)  signiﬁcant  differ-
nce in  the  group  compared  to  baseline  values.
0th  minutes  of  the  operation,  and  in  the  postoperative  6th
our  in  Group  BD;  and  in  the  12th  hour  comparing  with  Group
 (p  >  0.05)  (Fig.  2).
While  a  statistically  signiﬁcant  decrease  in  VAS  score  was
bserved  only  in  Group  BD  in  comparison  with  Group  C  in
ost-operative  0  min,  the  decrease  in  both  Group  B  and
roup  BD  in  between  the  postoperative  120th  min  and  the
th  hour  was  statistically  signiﬁcant  (p  <  0.05)  (Fig.  3).  The
ecrease  in  Group  BD  in  between  the  10th  and  24th  h  post-
peratively  was  statistically  signiﬁcant  when  compared  withPlease  cite  this  article  in  press  as:  Aksu  R,  et  al.  Efﬁciency  o
transversus  abdominis  plane  block  ultrasound  guided  in  posto
2016.  http://dx.doi.org/10.1016/j.bjane.2016.08.003
roups  C  and  B  (p  <  0.05)  (Fig.  3).
While  the  postoperative  morphine  consumption  in  Group
D  was  low  at  all  times
i
a
(aine +  dexmedetomidine.  (a)  Signiﬁcant  difference  from  group
; (b)  signiﬁcant  difference  from  group  B.
When  compared  to  Groups  B  and  C,  it  was  lower  in  Group
 than  Group  C  in  the  6th,  12th,  18th  and  24th  h (p  <  0.001)
Table  2).
There  was  no  signiﬁcant  difference  observed  among
roups  in  terms  of  the  number  of  patients  having  nausea-
omiting  scores,  antiemetic  requirement,  or  additional
nalgesic  administration  (p  >  0.05)  (Tables  2  and  3).
There  was  a  signiﬁcant  increase  in  terms  of  patient  sat-f  bupivacaine  and  association  with  dexmedetomidine  in
perative  pain  of  abdominal  surgery.  Rev  Bras  Anestesiol.
sfaction  scoring  in  Group  B  and  BD  compared  to  Group  C,
nd  also  in  Group  BD  when  compared  to  both  Group  B  and  C
p  <  0.001)  (Table  3).
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Figure  3  Postoperative  VASr  scores.  (a)  Signiﬁcant  difference  from  group  C;  (b)  signiﬁcant  difference  from  group  B.  VASr,  Visuel
Analog Scale  at  Rest.
Table  2  Postoperative  morphine  consumption  (mg)  and  additional  analgesic  need.  Data  are  given  as  mean  (SD)  or  number.
Group  C  (n  =  31) Group  B  (n  =  31) Group  BD  (n  =  31)  p
Postoperative  morphine  consumption
Postop.  120  min  5.0  ±  1.8  4.6  ±  2.0  2.2  ±  1.3a,b <0.001
Postop. 6  hour  12.3  ±  4.8  9.9  ±  4.1a 4.3  ±  2.4a,b <0.001
Postop. 12  hour  19.1  ±  6.6  13.5  ±  4.8a 6.4  ±  3.5a,b <0.001
Postop 18  hour  23.8  ±  4.7  15.6  ±  4.7a 7.2  ±  3.7a,b <0.001
Postop. 24  hour  28.8  ±  7.8  17.5  ±  4.6a 8.2  ±  3.9a,b <0.001
Additional analgesic  need  (n)
0--2  h  6  5  2  0.313
2--6 h  7  3  4  0.441
6--12 h  4  1  0  0.122
12--24 h  1  0  1  1.000
C, control; B, bupivacaine; BD, bupivacaine + dexmedetomidine.
a
r
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cSigniﬁcant difference from Group C.
b Signiﬁcant difference from Group B.
Discussion
It  has  been  stated  that  direct  blockade  of  abdomi-
nal  area  blocks  by  ilioinguinal  and  iliohypogastric  nerve
blocks  with  abdominal  wall  neural  afferent  nerves,  TAP
block  administration  following  abdominal  surgery,  such  as
inguinal  herniorrhaphy  and  hysterectomy,  provide  appropri-
ate  postoperative  pain  control.17--19 In  our  study,  TAP  block
administration  applied  after  anesthesia  induction  reduced
VAS  score  when  compared  to  the  control  group  and  at  the
same  time  reduced  postoperative  morphine  consumption.
In  order  to  provide  effective  postoperative  analgesia  with
TAP  block,  in  general  it  should  be  administered  soon  after
induction  of  the  block  and  soon  before  surgical  incision.19,20
Bharti  et  al.21 administered  TAP  block  at  the  end  of  thePlease  cite  this  article  in  press  as:  Aksu  R,  et  al.  Efﬁciency  o
transversus  abdominis  plane  block  ultrasound  guided  in  posto
2016.  http://dx.doi.org/10.1016/j.bjane.2016.08.003
operation  in  a  study  they  carried  out,  and  reported  that
it  did  not  prolong  time  to  ﬁrst  analgesic  request  in  com-
parison  with  the  control  group;  however,  they  reported
t
b
peduced  total  morphine  consumption  in  the  postoperative
nd  hour  and  thereafter.  Niraj  et  al.2 administered  unilateral
AP  block  with  20  mL  0.5%  bupivacaine  in  open  appen-
ectomy.  In  the  control  group,  the  mean  24  h morphine
onsumption  was  50  mg,  compared  to  28  mg  in  the  group
n  which  TAP  block  was  administered.  Cho  et  al.3 reported
hat  TAP  block  administration  with  20  mL  0.5%  bupivacaine
n  open  appendectomies  reduces  intra-  operative  fentanyl
onsumption  when  compared  to  the  control  group,  and
educes,  although  not  yet  statistically  signiﬁcantly,  the  time
o  ﬁrst  analgesic  administration,  and  does  not  change  the
ount  of  rescue  analgesic  requirement.  Furthermore,  they
eported  that  TAP  block  with  20  mL  0.5%  levobupivacaine
rovided  12  h  postoperative  analgesia;  its  effect  did  not
ontinue  up  to  24  h  postoperatively,  and  although  the  timef  bupivacaine  and  association  with  dexmedetomidine  in
perative  pain  of  abdominal  surgery.  Rev  Bras  Anestesiol.
o  ﬁrst  analgesic  administration  was  longer  in  the  TAP
lock  group,  it  was  not  statistically  different  when  com-
ared  to  the  control  group  (100.2  min  against  40.9  min).
ARTICLE IN PRESS+ModelBJANE-818; No. of Pages 8
6  R.  Aksu  et  al.
Table  3  Patient  satisfaction  scores,  patients  with  nause  and  vomitting  episodes  and  patients  receiving  antiemetics.  Data  are
given as  number  (%).
Group  C  (n  =  31)  Group  B  (n  =  31)  Group  BD  (n  =  31)  p
Patient  satisfaction  scores
Very  dissatisﬁed  0  (0)  1  (3.2)  0  (0)
Somewhat  satisﬁed  12  (39.8)  4  (12.9)a 0  (0)a,b <0.001
Rather satisﬁed  19  (61.3)  18(58.1)  17  (54.8)
Completely  satisﬁed  0  (0)  8  (25.8)a 14  (45.1)a
Nausea  and  vomiting
None  17  (54.8)  22  (71.0)  21  (65.6)
Nausea 7  (22.6)  3  (9.7)  6  (21.9)  0.129
Retching 6  (19.4) 5  (16.1) 4  (12.5)
Vomiting  1  (0.7)  1  (0.7)  0  (0)
Patients receiving  antiemetics  (n)
0--2 h  7  (22.6)  5  (16.1)  5  (16.1)  0.313
2--6 h  5  (16.1)  4  (12.9)  4  (12.9)  0.428
6--12 h 3  (9.7)  2  (6.5)  1  (3.2)  0.224
12--24 h  0  (0)  1  (3.2)  0  (0)  0.667
C, control; B, bupivacaine; BD, bupivacaine + dexmedetomidine.
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iSigniﬁcant difference from Group C.
b Signiﬁcant difference from Group B.
owever,  this  result  may  be  due  to  the  limited  number  of
atients.
Erdog˘an Arı  et  al.10 administered  TAP  block  with  20  mL
.125%  bupivacaine  in  open  inguinal  herniorrhaphy  and
dministered  0.25%  bupivacaine  at  the  end  of  surgery,  and
ound  the  same  postoperative  morphine  consumption.
However,  they  did  not  compare  its  effect  with  0.5%  bupi-
acaine.  Salman  et  al.19 administered  TAP  block  with  20  mL
.125%  bupivacaine  at  the  end  of  surgery  to  patients  with
nguinal  hernia  given  to  spinal  anesthesia  and  found  lower
ostoperative  morphine  consumption  than  in  the  control
roup.  In  our  study,  we  administered  TAP  block  with  20  mL
.5%  bupivacaine,  and  24  h  total  morphine  consumption  was
bserved  to  be  60.7%  lower  in  the  TAP  block  group  than  in
he  control  group.
TAP  block  duration  is  limited  to  the  action  time  of  admin-
stered  local  anesthesia.  In  several  studies  it  has  been
tated  that  addition  of  dexmedetomidine  to  local  anesthe-
ia  administered  to  central  neuroaxial  and  peripheral  block
rolonged  the  local  anesthetic  action  time  and  reduced
nesthetic  request.8,21,22 Agarwal  et  al.21 indicated  in  their
tudy  that  analgesia  time  was  prolonged  up  to  8  h  when  they
dded  100  g  dexmedetomidine  to  bupivacaine  in  a  supra-
lavicular  block.  Almarakbi  et  al.8 stated  that  in  a  study  in
hich  they  added  dexmedetomidine  to  bupivacaine  in  TAP
lock  in  abdominal  hysterectomy,  the  ﬁrst  time  to  analgesic
dministration  was  signiﬁcantly  longer  than  in  the  group
hat  dexmedetomidine  (470  min  and  280  min,  respectively)
nd  total  24  h  morphine  consumption  was  signiﬁcantly
ower  in  this  group  (19  mg  and  29  mg,  respectively).  In  our
tudy,  we  administered  TAP  block  with  20  mL  0.5%  bupiva-
aine  and  100  g  dexmedetomidine  +  bupivacaine  in  openPlease  cite  this  article  in  press  as:  Aksu  R,  et  al.  Efﬁciency  o
transversus  abdominis  plane  block  ultrasound  guided  in  posto
2016.  http://dx.doi.org/10.1016/j.bjane.2016.08.003
ppendectomy  and  open  inguinal  hernia  surgery,  and  the
4  h  morphine  consumption  in  the  control  group,  bupi-
acaine  group  and  bupivacaine  +  dexmedetomidine  group
as  28.8  mg,  17.5  mg,  and  8.2  mg,  respectively.  Morphine
c
o
vonsumption  in  the  2--24  h  period  in  both  groups  that  TAP
dministered  was  signiﬁcantly  lower  than  in  the  control
roup,  however,  lower  morphine  consumption  was  observed
n  the  bupivacaine  +  dexmedetomidine  group  in  all  24  h
easuring  periods,  including  the  ﬁrst  2  h,  when  compared
o  both  control  and  bupivacaine  groups.  In  this  regard,
exmedetomidine  is  considered  to  initiate  block  time  ear-
ier  and  to  prolong  action  time,  thereby  reducing  analgesic
onsumption.  In  general,  VAS  measurement  is  utilized  in
ostoperative  pain  studies.
Salman  et  al.19 found  that  postoperative  24  h  VAS  scores
n  open  inguinal  hernia  operations  were  lower  in  the  TAP
lock  with  20  mL  0.25%  bupivacaine  group  than  in  the  con-
rol  group.  Cho  et  al.3 assessed  patients  administered  with
AP  block  with  20  mL  0.5%  levobupivacaine  in  open  appen-
ectomy  with  verbal  numerical  rating  scale  for  pain  at  rest
VNRSr)  and  on  coughing  (VNRSc),  and  stated  that  VNRSr  was
2  h  and  VNRSc  was  postoperative  3  h  lower  than  the  control
roup.  Niraj  et  al.2 showed  that  in  open  appendectomy,  VAS
ssessment  at  rest  and  on  coughing  in  TAP  block  administra-
ion  with  20  mL  0.5%  bupivacaine  was  lower  in  the  30th  min
nd  24  h  postoperatively  when  compared  with  the  control
roup.
In  our  VASi  scoring  studies,  there  was  a  signiﬁcant
ecrease  in  Group  BD  in  0--24  h  when  compared  to  the  con-
rol  group  and  in  10--24  h  when  compared  to  Group  B.  In
he  BD  group,  there  was  a  decrease  in  2--8  h  in  comparison
ith  the  control  group.  While  in  TAP  block,  only  bupivacaine
dministration  provided  the  decrease  in  VASi  scores  for  8  h,
ddition  of  dexmedetomidine  prolonged  this  effect  up  to
4  h.  The  VASi  score  was  lower  in  the  postoperative  0  min
n  the  group  which  had  dexmedetomidine  added,  and  it  wasf  bupivacaine  and  association  with  dexmedetomidine  in
perative  pain  of  abdominal  surgery.  Rev  Bras  Anestesiol.
onsidered  that  dexmedetomidine  induces  sensorial  block
nset  earlier,  and  increases  block  efﬁciency.
Akın  et  al.22 administered  epidural  analgesia  with  bupi-
acaine,  and  bupivacaine  +  dexmedetomidine,  to  patients
 IN+Model
R
1
1
1
1
1
1
1ARTICLEBJANE-818; No. of Pages 8
Transversus  abdominis  plane  block  
undergoing  abdominal  surgery.  Patient  satisfaction  scores
in  the  group  to  which  dexmedetomidine  was  administered
were  signiﬁcantly  higher  than  in  the  control  group.  Kaur
et  al.23 found  no  statistically  signiﬁcant  difference  in  patient
satisfaction  scores  in  a  study  in  which  they  added  levobupi-
vacaine  dexmedetomidine  in  supraclavicular  brachial  plexus
block.  In  our  study,  there  was  a  signiﬁcant  increase  in  sat-
isfaction  scores  in  Group  B  when  compared  to  the  control
group  and  in  Group  BD  when  compared  to  both  the  control
group  and  the  bupivacaine  group.  In  all  groups,  rathet  sat-
isﬁed  rate  in  patient  satisfaction  scores  are  similar,  but  in
group  B and  group  BD  somewhat  satisﬁed  rate  was  lower  and
completely  satisﬁed  rate  was  higher.  So,  in  group  BD  patient
satisfaction  rate  was  higher.
In  this  study,  a  signiﬁcant  decrease  was  observed  in  HR
and  MAP  values  recorded  after  block,  in  comparison  with
pre-block  values  in  Group  B  and  BD;  however  the  effect  was
longer  in  Group  BD.
The  decrease  observed  in  hemodynamic  data  was  long-
lasting,  and  it  was  considered  that  it  might  be  its  role  in
blocking  response  to  stress  following  relief  of  postoperative
pain  with  dexmedetomidine  effect.  Patients  did  not  require
treatment  with  vasoactive  drugs.
Only  two  patients  in  Group  BD  had  intra-operative
atropine  request  due  to  bradycardia.
When  nausea-vomiting  scores  were  assessed  in  this  study,
there  was  no  statistically  signiﬁcant  difference  among
groups.  Administration  of  bupivacaine  and  dexmedetomi-
dine  for  TAP  block  did  not  elevate  nausea-vomiting  scores.
Almarakbi  et  al.8 indicated  that  50  of  sample  size  included
in  the  study  and  ﬁrst  degree  nausea  was  observed  in  3  sam-
ples  from  the  group  in  which  dexmedetomidine  was  added
to  bupivacaine  in  TAP  block,  and  11  samples  from  the  group
given  bupivacaine,  and  there  was  no  statistically  signiﬁcant
difference  among  samples  in  terms  of  nausea-vomiting  and
antiemetic  treatment.
As  a  result,  addition  of  bupivacaine  and  bupivacaine
dexmedetomidine  to  TAP  block  following  lower  abdomen
surgery  leads  to  a  decrease  in  HR  and  MAP  normal  clinical
levels  of  the  cases.  Addition  of  bupivacaine  dexmedetomi-
dine  reduced  morphine  requests  and  VAS  scores  in  the  24  h
postoperative  period.  Even  though  addition  of  only  bupi-
vacaine  reduced  24  h  morphine  consumption  in  comparison
with  the  control  group,  it  reduced  VAS  scores  effectively  for
hours.
It  has  been  found  that  postoperative  patient  satisfaction
scores  in  the  group  in  which  bupivacaine  dexmedetomidine
was  added  was  higher  than  in  the  other  two  groups.
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